Happy Thursday.

In today’s issue:

Angel funding rounds announced in recent weeks, compiled from public sources or via direct announcement. These deals represent the elite few that survived an angel network’s vetting process. Note: I have not personally analyzed these companies and am sharing for informational purposes only.

📊 Angel Network Investment Tracker: 274 Deals, 130 Networks.

🔓 The Exclusive: 21 Actively Raising Deals Shared to Date

Participating Group: Central Texas Angel Network

Axzon is developing NuroVault, a disposable peel-and-stick wireless logger that tracks the temperature of individual products in transit, which the company says costs less than $2. Central Texas Angel Network recently announced a $415K investment in the company.

Shahriar Rokhsaz | $415K Investment | Austin, TX | November 2026 | Source

Participating Group: Ohio State Early Investor Network

Superb Bakehouse (formerly Lopaus Point) produces gluten-free, dairy-free frozen waffles with no added sugar, and says they are sold at more than 1,000 retailers nationwide. Ohio State Early Investor Network recently announced an investment in the company.

Stacie Murphy Skinner | Columbus, OH | October 2026 | Source 1, Source 2

Participating Group: Nittany Angels

BioLattice Ophthalmics is developing CorneaClear, an engineered corneal implant intended as an alternative to donor tissue in transplants. Nittany Angels recently announced a $500K investment in the company as part of a $1.755M initial seed closing.

Linda Alunkal | $1.755M Seed | Philadelphia, PA | October 2026 | Source

Participating Group: Anges Québec

Bia is developing an AI tool that gives clinicians evidence-based guidance for bone, joint, and muscle care, and reports a pilot with 100 clinicians at Quebec’s provincial health agency. Anges Québec recently announced an investment in the company.

Anne-Sophie Paquet | $1.5M (C$2.15M) Pre-Seed | Quebec City, Canada | October 2026 | Source

Participating Group: Harvard Business School Alumni Angels of Greater New York

SavThera owns an over-the-counter wound care line for people and pets, including the FDA-cleared Rapid Seal bleeding-control gel it acquired from Medcura in July 2026. HBS Alumni Angels of Greater New York recently announced an investment in the company.

Tom Wollan | Riverdale, MD | October 2026 | Source

When an angel group backs a company, I contact the founder to ask if the round is open. If it is, members get the deck, my memo, and an intro to the founder.

They also get deals that come to me directly and never appear in this newsletter.

$50/month for the first 25 members. 10 seats left. Full refund within 30 days if you’re not enjoying it. Accredited investors only. I’ve shared 21 deals so far.

I see many angels write their first check into a consumer brand. The reasons for this are pretty straightforward: it’s simple to taste the product, hold it, and see it on the shelf at the grocery store. Way “easier” to wrap arms around than some super obscure cybersecurity tech product. But that approachability can trick investors into thinking that personally liking the product counts as diligence.

Alex Bodney, whose firm Midnight Venture Partners has backed well-known brands like Olipop, Happy Dad, Sesh, and more, calls it “falling in love with your own taste buds,” and he says the error cuts two ways:

Takeaway:

When evaluating a consumer product, be sure to contextualize your own preference: it’s just one data point. And frankly, you might be the weird one. Press for numbers that reflect thousands of other people’s reactions, and stay open to a deal even if you’d never personally buy the product.

Want more? Check out my full conversation with Alex 👇

Listen now on Apple Podcasts, Spotify, YouTube, and more.

Whisper in an open office and Wispr Flow still gets it right. Its own speech model, Canto, had the lowest error rate of every model tested, including Google and OpenAI. 4x faster than typing. Try Wispr Flow free.

Thanks for reading - have a great week.

-Andrew

If you’re finding this newsletter valuable, share it with a friend, and consider subscribing if you haven’t already. You can also find me on LinkedIn and X.

Advertise with The Diligent Observer.